Conference Call with Filatex India Ltd. Management and Analysts on Q3FY21 Performance and Outlook. Listen to the full earnings transcript. Management in attendance: CEO and MD Madhu Sudhan Bhageria, ED Ashok Chauhan, Senior VP Corporate Strategy Stuti Bhageria
We wish to inform that the Company today participated in virtual One on One Con-calls with White Oak Capital Management, Ashmore Investments and Edelweiss Securities and the Presentation(s) which was sent to the Stock Exchanges vide letter bearing REF:NS:SEC dated 10th November, 2020 and has been uploaded on the Company''s website with the link: https://www.mahindra.com/resources/investor-reports/FY21/Announcements/M-MQ2FY21- Earnings-call-Presentations-deck-10th-November-2020.pdf was shared with them.
Conference Call with Tata Elxsi Ltd. Management and Analysts on Q3FY21 Performance and Outlook. Listen to the full earnings transcript. Management in attendance: Manoj Raghavan, MD and CEO, Nitin Pai, Chief Strategy Officer, Muralidharan HV, CFO, and G Vaidyanathan, Chief Investor Relations Officer
Sub: EARNINGS CALL - FINANCIAL RESULTS FOR Q3 FY21 Ref.: Scrip ID - STLTECH/ Scrip Code - 532374 Dear Sirs, We wish to inform you that EARNINGS CALL to discuss the Company''s results and performance for the quarter ended December 31, 2020, is scheduled as below: Date & time 4.00 pm IST on Wednesday, January 20, 2021 Webinar Link https://stl-tech.zoom.us/webinar/register/WN_PtsFqScOSM67j1W1yEBDAw Further details are enclosed herewith. Kindly take this on your record and acknowledge the same.
We wish to inform that the Company today participated in virtual One on One Con-calls with Antique Institutional Equities and ICICI Pru Life Insurance and the Presentation(s) which was sent to the Stock Exchanges vide letter bearing REF:NS:SEC dated 10th November, 2020 and has been uploaded on the Company''s website with the link: https://www.mahindra.com/resources/investor-reports/FY21/Announcements/M-MQ2FY21- Earnings-call-Presentations-deck-10th-November-2020.pdf was shared with them.
Intimation about (1) significant business revival in Q3 of the current financial year, after business activities resumed across all states, and the growth in the non-covid business and (2) increase in volume of RT-PCR tests making us most cost effective service provider to the patients.
